Nasdaq:US$19.29 (+0.51) | HKEX:HK$30.20 (+0.30) | AIM:£3.05 (+0.08)
搜索结果
上一篇文章   |   下一篇文章
公告及新闻稿, 肿瘤学 / 免疫学 | 2007-05-23

Chi-Med completes patient enrolment on its HMPL-004 ulcerative colitis proof-of-concept; Phase II clinical trial in China